Clinical Trial

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Patients with Parkinson's Disease will be studied before, during, and after a deep brain stimulation implantation procedure to see if the stimulation location and the size of the electrical field produced by subthalamic nucleus (STN) DBS determine the degree to which DBS engages circuits that involve prefrontal cortex executive functions, and therefore have a direct impact on the patient's ability to inhibit actions.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-23; most recent amendment 2026-03-24.
Trial Details
NCT Number NCT06234995
Lead Sponsor Emory University
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions Parkinson Disease
Enrollment 80 participants
Start Date 2021-08-09
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-27